Back to stock search

Sight Sciences Inc

SGHT•NASDAQ•HEALTHCARESample data
$6.61+0.03 (+0.46%)
Market closed•Prev close $6.58
Save to watchlist

Research read

Monitor

Monitor only

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Analyst estimate

+29.2% ($8.5)

12-month analyst consensus · Source: Alpha Vantage

Support

No source-backed view is available for this stock yet.

Risk

Use the evidence panels below before acting.

Tracking

We show a live read only when source coverage is strong enough.

Set alertReview evidenceFundamentalsTechnicals

Section

Smart Money

Funds, insiders, influencers, and government demand tied to this stock — pulled straight from SEC filings, Form 4s, X posts, and federal award data.

Institutional

Who owns this in size

Live6 holders
  • Jim Simons

    Q1 2026 13F

    Jim Simons holds $1.1M

  • Citadel

    Q1 2026 13F

    Citadel holds $510K

  • Two Sigma

    Q1 2026 13F

    Two Sigma holds $479K

  • Point72

    Q1 2026 13F

    Point72 holds $372K

  • Marshall Wace

    Q1 2026 13F

    Marshall Wace holds $262K

  • FL

    Q1 2026 13F

    FMR LLC holds $31K

    • Insiders

    What insiders are doing

    Live9 trades

    • Sell· President and CEO, 10%· Cluster

      Badawi Paul sold $155K of Sight Sciences, Inc. · Jul 6

    • Sell· Chief Operating Officer· Cluster

      Bauerlein Alison sold $130K of Sight Sciences, Inc. · Jul 6

    • Sell· Chief Legal Officer· Cluster

      HAYDEN JEREMY B. sold $70K of Sight Sciences, Inc. · Jul 6

    • Sell· Chief Technology Officer· Cluster

      Badawi David sold $41K of Sight Sciences, Inc. · Jul 6

    • Sell· Chief Financial Officer· Cluster

      Rodberg James sold $37K of Sight Sciences, Inc. · Jul 6

    • Sell· EVP, Operations & R&D· Cluster

      Taylor Brenton sold $15K of Sight Sciences, Inc. · Jul 6

    Influencers

    What traders are saying

    No data yet

    No influencer mentions in the last 30 days.

    X/Twitter finance posts tracked by AlphaYou

    Govt contracts

    Federal awards tied to this company

    Checking USAspending awards...

    Section

    Fundamentals

    Business quality, valuation, analyst expectations, and the EPS quarter-over-quarter chart.

    Fundamentals

    Is the business strong?

    Live

    Valuation

    • P/E--
    • Forward P/E--
    • P/S3.51
    • P/B5.18

    Quality

    • Profit margin-46.8%
    • Operating margin-35.6%
    • ROE-56.6%
    • ROA-14.3%

    Growth

    • Revenue YoY--
    • Earnings YoY--
    • Beta2.40
    • Dividend yield--

    Snapshot

    Quick facts

    Updated Jun 16
    Market cap
    $279.1M
    52-week range
    $3.11 - $9.24
    Volume
    4.21M
    Sector
    HEALTHCARE

    Analysts

    What do analysts expect?

    Live

    Current

    $6.61

    Target

    $8.54

    Earnings

    Did earnings help or hurt?

    Live
    $-0.05$-0.12$-0.19$-0.26$-0.33Q2 '24Q4 '24Q2 '25Q4 '25Q1 '26
    BeatMissMatchEstimate

    Section

    Technicals

    Price trend, moving averages, 52-week range, and chart behavior.

    Price

    Stock chart

    0reads marked

    Technicals

    Chart health

    Live

    Trailing returns

    • 5d+0.30%
    • 20d+2.64%
    • 60d+5.09%

    Trend vs moving averages

    • vs SMA50+2.01%
    • vs SMA200+5.37%

    52w range position

    $3.1157%$9.24

    Based on daily price data. Options flow and order-book data are not in this chart panel yet.

    Section

    Macro

    Sector rotation, market regime, policy, and event-window context.

    Macro

    Market backdrop

    No data yet

    No major macro issue for this stock right now.

    Sector rotation and market regime changes show here when they matter.

    Section

    News

    Catalysts, filings, and market-moving events when they matter.

    News

    Catalysts and headlines

    No data yet

    No major news catalyst found yet.

    Catalysts, filings, and event windows show here when they matter.

    Section

    Derivatives

    Options flow, volatility regime, gamma pressure, and positioning when available.

    Derivatives

    Options and positioning

    No data yet

    No derivative pressure found yet.

    Options flow, gamma, and volatility signals show here when available.

    +1.93 (+29.2%) possible upside12 months

    12-month analyst consensus · Source: Alpha Vantage